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A domestic cat whole exome
sequencing resource for trait
discovery
Alana R. Rodney1,12, Reuben M. Buckley2,12, Robert S. Fulton3, Catrina Fronick3,
Todd Richmond4, Christopher R. Helps5, Peter Pantke6, Dianne J. Trent7, Karen M. Vernau8,
John S. Munday9, Andrew C. Lewin10, Rondo Middleton11, Leslie A. Lyons2 &
Wesley C. Warren1*
Over 94 million domestic cats are susceptible to cancers and other common and rare diseases. Whole
exome sequencing (WES) is a proven strategy to study these disease-causing variants. Presented is a
35.7 Mb exome capture design based on the annotated Felis_catus_9.0 genome assembly, covering
201,683 regions of the cat genome. Whole exome sequencing was conducted on 41 cats with known
and unknown genetic diseases and traits, of which ten cats had matching whole genome sequence
(WGS) data available, used to validate WES performance. At 80 × mean exome depth of coverage,
96.4% of on-target base coverage had a sequencing depth > 20-fold, while over 98% of single
nucleotide variants (SNVs) identified by WGS were also identified by WES. Platform-specific SNVs
were restricted to sex chromosomes and a small number of olfactory receptor genes. Within the 41
cats, we identified 31 previously known causal variants and discovered new gene candidate variants,
including novel missense variance for polycystic kidney disease and atrichia in the Peterbald cat. These
results show the utility of WES to identify novel gene candidate alleles for diseases and traits for the
first time in a feline model.
Genomic medicine promises new avenues of disease treatment in veterinary medicine1. However, the appropriate
resources are not yet readily available for robust implementation in clinical practice2. One resource which has
been successfully applied to the diagnosis of rare diseases in humans is whole exome sequencing (WES) analysis, a cost-effective method for identifying potentially impactful DNA variants in the coding regions of g enes3.
DNA base changes in the exome can alter amino acids in proteins or disrupt their overall structure, so focusing
on these regions offers a more direct and biologically interpretable approach to searching for putative disease
variants. In comparison, whole genome sequencing (WGS) captures DNA variants spanning the entire genome.
However, as the vast majority of the identified variants are within non-coding regions, much of the variation
is difficult to interpret. The present study seeks to develop and validate the use of WES as a viable approach for
determining novel disease variants in cats.
Over the last decade, a surge of studies using next generation sequencing (NGS), in particular WES, has led
to many novel discoveries of candidate disease-causing variants across species. WES is recognized as an efficient means for genome resequencing and is the primary NGS approach used to help diagnose human patients
with rare genetic d
 iseases4,5. By selectively sequencing all protein-coding regions to a deeper depth than WGS,
WES is a dependable method for finding biallelic exonic variants causative of Mendelian inherited diseases
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that rarely appear in healthy populations4,5. In humans, WES is commonly used to find genetic causes in a wide
range of diseases, even complex neurological conditions such as autism spectrum d
 isorder6. Its widespread use
has led to the discovery of therapeutic targets for drug development and genetic markers for innovative clinical
applications7. Tumor WES has been especially successful by cost-effectively providing somatic variant information about a patient’s normal and tumor exomes, supporting the identification of recurrent somatic mutations
among known oncogenes that may suggest a mechanism of action and targets for potential drug t herapies8. The
significant depth of exome coverage is integral to overcoming diluted somatic variant allele frequencies (VAF)
due to tumor clonality and purity issues.
Exome sequencing has also proven successful in non-human species. Mouse WES studies have found strong
candidate alleles for models of orofacial clefting, urogenital dysmorphology, and autoimmune hepatitis9. In
companion animals, the development of dog WES has demonstrated that causative allele discovery for common
diseases has great potential10. Some examples in dogs include the discovery of a two-base pair deletion in SGCD
causing muscular dystrophy, and a splice site variant in INPP5E which is associated with cystic renal d
 ysplasia11.
As there are many isolated breeds of domestic dogs, this species is an important genetic resource for cancer
studies, for which WES demonstrated dogs have similar oncogene variant patterns to humans12. However, many
oncogene variants are not equivalent to a WES analysis of human, and canine bladder cancers identified novel
mutations in FAM133B, RAB3GAP2, and ANKRD52 that are unique to canine bladder cancer, emphasizing the
need to understand the biological differences in o
 rigin13.
Similar to canines, domestic cats have long been recognized for their potential in modeling human diseases, such as retinal b
 lindness14,15. Approximately 150 variants in domestic cats are associated with over 100
genetic traits or diseases, many mimicking human disease phenotypes16. As feline genomic resources continue to
advance, more diseases caused by single base variants are being discovered, such as two novel forms of blindness
in Persian and Bengal cats17,18. However, a feline WES resource has not been described to date for the discovery
of novel disease gene candidates. Here we describe the first feline exome resource, a WES analysis of 41 cats, and
its use in the discovery of known and novel variants associated with feline phenotypes, healthy and diseased. A
comparison of WES and WGS methods was also completed to understand the efficiency, depth of coverage, and
sequence specificity, for variant calling from each approach.

Results

Phenotype cohort. WES was performed on 41 individual cats, representing a variety of different diseases
and traits, some with known disease alleles (Table 1). The 41 cats can be further divided into two separate
cohorts: the first is the initial ten cats that had nine known variants for various diseases and aesthetic traits, e.g.,
coat colors and fur types. These 10 cats also had matched WGS data, which was used to assess the efficacy of
WES. The second cohort of 31 represents genetically uncharacterized cats. These cats represented 11 different
breeds and include 14 random-bred cats. Groups of cats with similar genetic backgrounds were used to evaluate
causes for mediastinal lymphoma, a seizure disorder, eyelid colobomas, hypothyroidism, hypovitaminosis D,
blue eyes of Ojos Azules breed, and curly hair coat of the Tennessee Rex. Five cats were reported with cardiac
diseases, including hypertrophic cardiomyopathy (HCM). At least seven neurological disorders are represented
in the study population, generally representing novel presentations in random-bred cats. Overall, the 41 cats had
approximately 31 different unknown disease presentations.
Sequence coverage and specificity.

To assess the performance of this feline exome resource, deep coverage WES data was produced for ten cats with WGS data for comparison. After mapping to Felis_catus_9.0,
base quality trimming, and PCR duplicate removal, the average percentage of reads uniquely mapped was 82%
(Table 2). The average sequencing depth was 267 × with a range of 76 × to 458 × (Supplementary Table 2, Supplementary Data S1). Assessing the depth of coverage, of the 201,683 exonic targets, 98.1% aligned with coverage
of > 20 ×. An average of 6.98% of the total reads aligned outside of the targeted regions of the genome. (Supplementary Table 2, Supplementary Data S1). For the uncharacterized 31 cat exomes, the sequencing depth was
adjusted to typical human WES studies; for this group of cats, we estimated the average depth of coverage to be
80 ×. 96.41% of exonic targets aligned with a coverage of > 20 ×, ranging from 91 to 98%. An average of 10.41%
of total reads aligned off-target is slightly higher when compared to the first 10 higher-coverage cats that can be
attributed to lower sequencing depth in the larger cohort. As expected, overall there is a reduction in mapping
at lower depth of coverage; for example, at 40 ×, 93.5% of targeted bases were covered (Fig. 1), conversely, 99%
are covered at 2 ×.

Platform‑based variant discovery and associated biases. Variants were divided into those found

using both WES and WGS platforms and those exclusive to one platform. Both sets were then filtered for quality,
variant type (SNV or indel), and biallelic status. For high impact variants causing a loss of function in the gene,
WES and WGS identified 582 and 617 SNVs, respectively, with 97.8% of the WES SNVs also identified by WGS
and 92.1% of the WGS SNVs also identified by WES (Table 3). The most common classes of variants identified
exclusively by WGS were splice donor/acceptor sites and stop gains; however, the overall count of these variants
was low, ranging from 3 to 19 total variants. Moderate (missense) and low (synonymous) impact variants had
high concordance between the WES and WGS datasets, ranging from 94.7% for 3′ untranslated region SNVs in
WGS to 100% for most SNVs identified by WES (Table 4). Altogether, only a small fraction of SNVs (WES = 834
and WGS = 2194) were exclusive to a particular platform (Fig. 2a). Considering indels identified by haplotype
caller, the WES and WGS data had lower concordance than SNVs (Table 5). Although WES detected 1739 high
impact indels and WGS detected 1931, the percentage of commonly identified and exclusive indels showed more
variation between consequence categories than SNVs. For both SNVs and indels, those classified as high impact
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No

Id

Breed

Sex

Disease/Trait

Gene(s)

1

19725

Lykoi

F

Lykoi

HR

2

13230

Mixed Breed

F

Bengal PRA/Bobbed tail

KIF3B/HES7

3

14056

Mixed Breed

M

Persian PRA/Long

AIPL1/FGF5

4

17994

Mixed Breed

F

Hydrocephalus

GDF7

5

19067

Munchkin

F

Dwarfism/Dominant White

UGDH/KIT

6

5012

Oriental

M

Lymphoma

Unknown

7

20382

Peterbald

M

Hairless

LPAR6a

8

11615

Random Bred

M

Dominant White

KIT

9

18528

Random Bred

M

Spotting

KIT

10

20424

Siberian

F

Long/Cardiac disease

FGF5/Candidate

11

22550

Bengal

F

Polyneuropathy

Unknown

12

20957

Devon Rex

U

Papilloma virus

Unknown

13

22752

Devon Rex

M

Neurological disorder

Unknown

14–15

21983/21464

Ojos Azules

1M:1F

Ojos Azules

Unknown

16

20964

Oriental

F

Cardiac disease

Unknown

17

22728

Random bred

F

Cystinuria

SLC3A1a

18

20617

Random Bred

M

Neuronal ceroid lipofuscinosis

CLN6a

19

20948

Random Bred

M

Cinnamic acid urea

Unknown

20

21153

Random Bred

M

Ambulatory paraparesis

Unknown

21

22287

Random Bred

F

Myotonia congenita

Unknown

22

22397

Random Bred

M

Neurological disorder

Unknown

23

22505

Random Bred

M

Cardiac disease

Unknown

24

22623

Random Bred

U

Pycnodysostosis

Candidate

25

22740

Random Bred

F

Epidemolysis bullosa

Unknown

26–27

22741/22742

Random Bred

1F:1M

Eyelid coloboma

Unknown

28

22751

Random Bred

M

Ehlers-Danlos

Unknown

29–30

22763/22764

Random Bred

2F

Hypothyroidism

Candidate

31–32

22761/22762

Savannah

2M

Hypovitaminosis D

Unknown

33

21984

Scottish Fold

F

Cardiac disease

Candidate

34–35

20384/20385

Selkirk Rex

1F:1U

Seizures

Unknown

36

20953

Siamese

F

Cardiac disease

Candidate

37

22622

Siberian

U

PKD

PKD2a

38

22711

Singapura

F

Hypovitaminosis D

Candidate

39–40

8641/8642

Tennessee Rex

1F:1M

Rexoid hair coat

Unknown

41

6623

Unknown

41

Oriental

M

Lymphoma

14 breeds

19F:18M:4U

~ 31 diseases and traits

Table 1.  Description and diseases of 41 cats for WES evaluation. A complete description of diseases and
traits for entire cohort. Candidate genes are potential genes that been identified with less evidence of a causal
mutations. U unknown sex, F female, M male. a Mutations as tentative causal variants for diseases presented.

Depth of coverage

Average-First 10

Range-First 10

Average-Cohort of 31

Range-Cohort of 31

267 ×

76–485 ×

80 ×

60–108 ×

% of bases covered

99.1%

92.3–100%

96.4%

91–98%

% reads aligned

99.9%

99.9–100%

82%

75–85%

Table 2.  Summary of Metrics across both cohorts.

represented a disproportionate number of the platform exclusive variants. Across both platforms, each individual cat carried a total of approximately 80,000 SNVs within the exome target regions (Fig. 2b). As for platform
exclusive SNVs, WGS SNV counts were elevated compared to WES SNV counts and also showed higher levels
of variability between individuals (Fig. 2c).
Another method for characterizing platform exclusive SNVs is to measure their allele count distributions.
WES exclusive SNV allele counts were heavily skewed towards allele counts of one (Fig. 2d). Using SNVs found
in both platforms as a standard for comparison, the WES exclusive allele count distribution is consistent with
SNVs identified by random error, as most of these SNVs only appear once in the dataset. Moreover, this result is
reflected by the Ti/Tv ratios of each dataset, the proportion of transitions to the number of transversions, which
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1

Proporon of Bases Covered

0.9
0.8
0.7
0.6
0.5
10x

20x

30x

40x

50x

Minimum depth of Coverage (x)

Figure 1.  The proportion of bases covered with the exome capture probes. The initial 10 samples are colored
in red, with the X axis showing the depth of coverage, which is how many times a nucleotide base is covered
starting at a depth of 10x and increasing to 50x.

WES (%)

WGS (%)

Impact

Consequence

Common

Exclusive

Total

Common

Exclusive

Total

High

Frameshift

1440 (93)

109 (7)

1549

1451 (84.8)

260 (15.2)

1711

High

Splice acceptor

High

Splice donor

69 (83.1)

14 (16.9)

83

71 (69.6)

31 (30.4)

102

107 (88.4)

14 (11.6)

121

107 (81.1)

25 (18.9)

132

High

Start lost

11 (100)

0 (0)

11

11 (84.6)

2 (15.4)

13

High

Stop gained

16 (76.2)

5 (23.8)

21

17 (56.7)

13 (43.3)

30

High

Stop lost

High

All

12 (92.3)

1 (7.7)

13

12 (85.7)

2 (14.3)

14

1602 (92.1)

137 (7.9)

1739

1615 (83.6)

316 (16.4)

1931

Moderate

Inframe deletion

709 (90.5)

74 (9.5)

783

710 (91.1)

69 (8.9)

779

Moderate

Inframe insertion

557 (92.4)

46 (7.6)

603

557 (90)

62 (10)

619

Moderate

Protein altering

Moderate

All

13 (81.3)

3 (18.8)

1267 (91.2)

122 (8.8)

16

13 (54.2)

1389

1268 (90.1)

11 (45.8)
139 (9.9)

24
1407

Low

3′ UTR

173 (91.5)

16 (8.5)

189

176 (81.5)

40 (18.5)

216

Low

5′ UTR

194 (96.5)

7 (3.5)

201

195 (91.5)

18 (8.5)

213

35 (5.2)

49 (7.1)

693

Low

Splice region

641 (94.8)

676

644 (92.9)

Low

Start retained

7 (100)

0 (0)

7

7 (100)

Low

Stop retained

10 (100)

0 (0)

10

10 (83.3)

Low

All

299 (94.3)

18 (5.7)

317

302 (92.9)

23 (7.1)

325

All

4333 (92.5)

351 (7.5)

4684

4364 (87.8)

609 (12.2)

4973

0 (0)
2 (16.7)

7
12

Table 3.  Indel consequence counts of WES versus WGS as determined by variant effect predictor.

is used as a quality indicator for SNVs. WES SNVs found in both platforms have a Ti/Tv ratio of 3.92, indicating
a low concentration of false-positive variant sites, while WES exclusive SNVs have a ratio of 1.52, indicating a
high concentration of false-positive variant sites. Alternatively, allele counts for WGS exclusive SNVs have two
peaks. The first is at an allele count of one, which is similar to WES exclusive SNVs, and the second is at an
allele count of four, which is suggestive of more systematic error in variant detection. This second peak for WGS
exclusive SNVs is likely consistent with the increased WGS exclusive variant detection observed in male cats
and may be suggestive of issues stemming from the lack of a Y chromosome within the reference assembly that
was used. For WGS SNVs, the Ti/Tv ratios for both exclusive and non-exclusive SNVs is similar to WES SNVs,
where exclusive SNVs are enriched for false-positive variant sites.
To detect bias toward specific genes using the WGS and WES platforms, the number of variants per gene was
compared between WGS and WES results (Supplementary Data S2). When comparing variants discovered by
WGS and WES, a large number of genes contained 20 or more variants discovered by WGS (Fig. 3). To investigate
the cause for these outliers, the top 50 outlier genes were selected for further analysis (Supplementary Data S3).
Of these, 14 genes were found on the X chromosome, suggesting differences in variant detection may correspond
to the increased number of WGS exclusive SNVs in males observed in Fig. 2c (Supplementary Data S3). Apart
from enrichment on chromosome X, another cluster of 13 genes with WGS-biased variant detection was located
on chromosome D1. These genes were mostly olfactory receptors, which generally belong to large gene families
with many paralogues and pseudogenes, likely leading to increased off-target effects. Another gene of note,
LOC101099449, contained 713kbp of the target sequence. When analyzed more closely, LOC101099449’s target
Scientific Reports |
Vol:.(1234567890)

(2021) 11:7159 |

https://doi.org/10.1038/s41598-021-86200-7

4

www.nature.com/scientificreports/

WES (%)
Impact

Consequence

High

Splice acceptor

High

Splice donor

High

Start lost

High

Stop gained

High

Stop lost

High

All

Moderate
Moderate
Low

Common
97 (97)

WGS (%)
Exclusive

Total

Common
98 (89.9)

Exclusive

Total

3 (3)

100

137 (97.9)

3 (2.1)

140

63 (96.9)

2 (3.1)

65

63 (100)

0 (0)

63

237 (97.9)

5 (2.1)

242

232 (92.8)

18 (7.2)

250

139 (88)

11 (10.1)

109

19 (12)

158

35 (100)

0 (0)

35

36 (97.3)

1 (2.7)

37

569 (97.8)

13 (2.2)

582

568 (92.1)

49 (7.9)

617

missense

43,518 (99.3)

309 (0.7)

43,827

43,419 (98.1)

821 (1.9)

44,240

All

43,516 (99.3)

309 (0.7)

43,825

43,417 (98.1)

821 (1.9)

44,238

3′ UTR

2022 (97.9)

43 (2.1)

2065

2031 (94.7)

114 (5.3)

2145

Low

5′ UTR

2458 (99.5)

13 (0.5)

2471

2459 (98.6)

35 (1.4)

2494

Low

Splice region

3938 (99.5)

21 (0.5)

3959

3923 (98.7)

50 (1.3)

3973

Low

Stop retained

60 (100)

60

58 (96.7)

2 (3.3)

60

Low

Synonymous

87,341 (99.6)

321 (0.4)

87,662

87,182 (98.9)

956 (1.1)

88,138

Low

All

88,584 (99.6)

336 (0.4)

88,920

88,417 (98.9)

975 (1.1)

89,392

All

All

144,012 (99.4)

834 (0.6)

144,846

143,745 (98.5)

2194 (1.5)

145,939

0 (0)

Table 4.  SNV consequence counts of WES versus WGS as determined by variant effect predictor.

Figure 2.  Variant calling statistics for 10 cats sequenced on both platforms. (a) Venn diagrams showing the
number of exclusive and common variants per platform. Dark red text indicates the number of variants found
in WES and black text indicates the number of variants found in WGS. The reason the number of common
variants differ between platforms is because common variants were identified prior to filtering. (b) The number
of SNPs found in each sample in both platforms. (c) The percentage of SNPs found as exclusive to each sample
for each platform. The first, third, eighth, and tenth samples are males. All other samples are female. (d) Allele
count distribution for common and exclusive SNPs in both platforms. WES SNPs are shown on top and WGS
SNPs are shown upside down on the bottom. In addition, the Ti/Tv ratio for sets of SNPs is also shown.
sequence overlapped an entire Immunoglobulin lambda locus, a region that is usually highly variable between
individuals. All other genes with WGS-biased variant detection were distributed throughout the genome.
To further investigate increased WGS-biased variant detection on chromosome X, the mean number of
variants per individual was compared between males and females (Table 5). Across autosomes and sequencing
platforms, sex-based percentage differences were relatively low, ranging between 7 and 10%. Alternatively, across
both gene groupings, the percentage difference between the sexes on the X chromosome were much higher. For
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Genes

Top 50 WGS outliers

Platform

WGS

Sex

Male

Female

WES
Difference (%)a

Male

Female

Difference (%)a

Autosome

1595.00

1445.67

149.33 (9.36)

946.25

872.83

73.42 (7.76)

X chromosome

1363.75

22.83

1340.92 (98.33)

829.75

23.00

806.75 (97.73)

Genes

All

Platform

WGS

Sex

Male

Female

Difference (%)a

Male

Female

Difference (%)a

Autosome

53,724.75

57,605.50

3880.75 (7.22)

53,189.50

57,217.67

4028.17 (7.57)

1968.50

766.00

1202.50 (61.09)

1412.00

776.33

X chromosome

WES

635.67 (45.02)

Table 5.  Mean SNVs per individual for ten WES and WGS cats. a Percentage differences in parentheses were
calculated as a fraction of mean SNVs per male individual.

Figure 3.  Gene-wise platform bias. Each individual point on the scatterplot is a gene with the y axis displaying
differences in SNP counts per gene. Genes with more WGS SNPs than WES SNPs have positive values, where
genes have negative values when there is more WES SNPs instead. Expected SNP number is calculated as the
mean number of SNPs per gene across both platforms and is plotted on a log scale.

the top 50 WGS outlier genes, both platforms showed an approximate 98% sex difference, whereas all genes
showed a 61% sex difference for WGS and a 45% sex difference for WES. Since the percentage sex difference in
outlier genes is similar across both platforms, results suggest that platform bias on chromosome X is more likely
due to platform exclusive increased variant detection in these regions, rather than differential abilities of platforms to detect variants in either sex. Importantly, the actual number of chromosome X sex differences in both
platforms is similar across gene groupings. In the top 50 WGS outliers, the difference between the chromosome
X mean male and female SNV counts is 1340.92, while across all X chromosome genes this same difference is
equal to 1202.5 (Table 5).
To examine the potential overlap between platform and sex bias, the distribution of SNVs per gene along
chromosome X were analyzed. Platform biased genes are clustered between positions 15 to 70 Mb (Fig. 4a).
Across both platforms, these genes also have the highest SNV concentration, with > 20 SNVs per kb of coding
sequence (Fig. 4a). Alternatively, the majority of genes outside this region have SNV concentrations of < 5 SNVs
per kb of coding sequence. Regarding sex bias, while the overall percentage difference across platforms is similar
(Table 5), individual genes show platform exclusive variability in effect size. For example, male biased variant
detection on a per gene basis was observed more often for WGS (Fig. 4b). However, despite this variation across
platforms, the genes with increased sex bias were the same genes with increased platform bias (Supplementary
Data S4). Therefore, on chromosome X, platform biases and sex biases in SNV discovery appear confounded, as
numerous factors within the same genes are relatively consistent across both platforms, both biases likely have
a similar underlying root cause differently expressed in each platform.
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Figure 4.  Distribution of SNPs per gene along chromosome X. (a) Total SNPs per kb of coding sequence per
gene. (b) Sex biased variant detection along chromosome X. Bias is calculated as fold change ratio between the
mean number of SNPs per individual per gene for males and females. Specifically, this was calculated for each
gene as log2((mean male SNPs + 1)/(mean female SNPs + 1)). The ones were added to remove undefined results
caused by dividing by the number 0.
A potential cause of sex bias in variant discovery is that the biased genes have degraded copies on the Y chromosome. For the ten known feline X chromosome genes with degraded Y copies19, the total number of SNVs
per platform and the mean number of SNVs per individual were calculated. Of these ten genes, nine have more
than 11 platform exclusive differences in SNV discovery and are therefore among the top 50 outlier genes for
platform exclusive bias (Supplementary Table 4). Moreover, almost all SNVs found in these genes were found
only in males, regardless of platform. For WGS there was an average total of 1169.25 SNVs found in males with
only an average total of 7.83 found in females. For WES, the numbers were similar, with an average total of 774.5
SNVs found in males and an average total of 7.83 SNVs found in females (Supplementary Table 4). Together
these results indicate a major portion of sex bias in variant discovery is due to the absence of a Y chromosome
in the Felis_catus_9.0 assembly.

Known variant validation. To further analyze the effectiveness of WES for variant detection, we exam-

ined each sample for the presence of known trait-causing variants. The Felis_catus_9.0 Ensembl release 99 gene
annotation was used with a selection of exons with + /− 30 bp to match exome capture design and variants were
browsed using the VarSeq software (GoldenHelix, Inc). The majority of the previously published 115 trait causing variants in the domestic cat that have been documented as causal for diseases and traits affect either the
coding regions or a splice donor/acceptor s ite16. Of these known variants, 44 were identified in our WES cohort.
All variants for coat colors and diseases expected to be present in the ten cats were identified, including the
alleles in the loci for Agouti (ASIP—a20), Brown (TYRP1—b21), Color (TYR—cs22), Dense (MLPH—d23), Longhair (FGF5—I24), Lykoi (HR—hrTN, hrVA25), Bengal progressive retinal degeneration (KIF3B26) and Persian
progressive retinal degeneration (AIPL117), hydrocephalus (GDF727), and others (Supplementary Data S5). The
cats also had variants known to affect cat blood type as w
 ell28,29. In accordance with the limitations of our feline
exome capture design, neither known structural nor intronic variants were detected. When analyzing discordant
reads in a WGS dwarf sample, a deletion and rearrangement indicating a structural variant (SV) was visible in
the UDGH gene17, but no read discordance was found in the WES analysis (Supplementary Fig. 1). In addition,
the KIT intron one SV for White and Spotting were not identified30. Therefore, the WES approach will fail to
identify many complex SVs, an important limitation to consider for future feline trait discovery efforts.

Novel candidate variant discovery. Novel DNA variants were explored as putatively causal for diseases
and traits in 33 cats. A novel frameshift mutation in polycystin 2 (PKD231), a gene associated with polycystic
kidney disease (PKD) was predicted to disrupt protein function in a Siberian cat shown by ultrasound to have
PKD. This mutation, a single-base deletion, causes a truncated protein (p.Lys737Asnfs*2). This variant was heterozygous in the affected cat and unique to the exome data and was not identified in the 195-cat cohort of the 99
Lives variant d
 ataset32. This variant was also identified in both grandparents on the dam’s side of the pedigree,
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although kidney ultrasound was not available. However, analysis of other Siberian cats with PKD diagnosed by
ultrasound failed to identify the c.2211delG variant in PKD2, suggesting that this could be a private variant and
that other disease-causing PKD variants are yet to be discovered in this breed.
A variant in the lysophosphatidic acid receptor 6 (LPAR6) gene associated with the autosomal recessive rexoid
(Marsella wave) coat of the Cornish rex breed was detected in a Peterbald cat, which is a hairless breed33. However, the hairless trait is considered autosomal dominant by cat breeders. The annotation predicts a c.249delG
causing a p.Phe84Leufs*10; therefore, this Peterbald cat likely is compound heterozygous for two mutations
juxtaposed in LPAR6. This variant was heterozygous in the affected cat, unique to the exome data and not identified in the 99 Lives variant dataset.
A known feline disease variant was also re-identified (Supplementary Data S5)32. A solute carrier family
3-member 1 (SLC3A1) variant was homozygous in a Greek cat presenting with cystinuria. The c.1342C>T variant, causing a p.Arg448Trp at position A3:66539609 has been previously documented to be associated with this
condition34. No other cat in the exome dataset had this variant. Many of the variants associated with cat blood
group B and its extended haplotype were detected in 11 cats, suggesting five cats as type B, one was c onfirmed28.
Variants were detected in APOBEC3, which is associated with feline immunodeficiency virus (FIV) infection in
cats, and three cats had the allelic combination producing the IRAVP amino acid haplotype that is associated
with FIV r esistance35. Novel findings included two cats that were heterozygous for a porphyria variant in UROS
(c.140C>T, c.331G>A)36,37, one cat which was homozygous for FXII deficiency variant (FXII_1631G>C)36, and
had died as a kitten, and one cat which was heterozygous for a copper metabolism deficiency in ATP7B38. Additional variants for neuronal ceroid lipofuscinosis, pycnodysostosis, Ehlers-Danlos syndrome, hypothyroidism,
and hypovitaminosis D, and several individual-specific variants for hypertrophic cardiomyopathy are under
further investigation (Table 1).

Discussion

In humans, WES has flourished over the past few years and is becoming more common in the practice of genomic
medicine, especially newborn s creening39. This is not currently the case for veterinary medicine due to several
factors: a dog or cat owner’s unwillingness to incur the costs, lower accuracy of available genome r eferences40,
and the uncertainty of treatment options driven by sequence variant data. Well-annotated genomes and extensive
resources, such as for human and mouse, have led to the development of various exome capture products ranging from those with a very limited focus, e.g., oncogene panels, to more extensive designs including 5′ and 3′
untranslated regions, predicted regulatory elements, and non-coding RNAs. For other mammals, exome capture
designs have ranged from 44.6 Mb in pigs41 to 146.8 Mb in rats42,43, illustrating the variation in experimental
objectives. In companion animals, only the domestic dog has exome capture probes available, which span 53 to
152 Mb with an overlap of 34.5 Mb between the capture designs44,45. In this study, a feline exome resource was
developed by designing capture probes against the annotated Felis_catus_9.0 genome assembly, a highly contiguous assembly that enabled efficient probe d
 esign40. The targeted 35.7 Mb accounts for the exons and 30 bp
of flanking sequences to minimize the loss of detectable splice donor and acceptor variants.
Success in disease variant identification in any species using WES is dependent on multiple factors, including
mode of inheritance, sequencing depth, and efficient probe design that covers the regions of interest with high
specificity, minimizing the number of off-target reads. Sequence coverage of ≥ 20 × is generally regarded as the
standard to efficiently detect heterozygous variants46. At this threshold, an acceptable average target coverage of
96.4% was obtained in our study. In our first WES experiment of 10 cats, we achieve maximum exonic coverage of
99% with a mean depth of 267 × at aligned bases. However, we have found this high-depth approach is not necessary or cost-efficient for the discovery of feline associated disease variants. The first domestic dog exome d
 esign44,
which covered 52.8 Mb distributed over 203,059 regions, had a range of 87–90% mapped reads at a 102 × mean
sequencing depth. An updated canine d
 esign44 had 93.5% of the targeted bases (< 53 Mb) covered to at least 1X
depth of coverage, while in our feline exome design, the on-target reads were nearly 100% at 10 × sequencing
depth. Whilst absolute dog and cat exome comparisons are difficult due to the differences in annotation, genome
assembly accuracy, and design techniques, both of these resources reveal acceptable performance.
The intended application of the cat WES was twofold: the identification of heritable, Mendelian diseases and
traits, and somatic mutations in cancer. In this study, the focus was the former and included the assessment of
the efficiency of the feline exome design for SNV discovery against ten matched WGS samples. The matched
WGS and WES cats had an average of 30 × and 267 × depth of coverage, respectively, with the vast majority of
SNVs and indels in overlapping regions being detected by both platforms. Altogether, these findings suggest the
use of this feline exome probe set was extremely consistent with variant discovery from WGS, where 99.4% were
uncovered in WGS while only 1.5% were absent from the WES cats. Consistent with large cohort human studies, indel discovery was less consistent (92.5% overlap) with 12.2% of WGS indels absent from WES data owing
to the well-known short-read misalignment problem in regions with indels of varying size. Differences in the
number of common variants between platforms is due to differential filtering, as common variants were identified
prior to when filtering was performed. The percentage of exclusive variants per platform also varied according
to variant impact, with high impact variants representing the largest percentage of exclusive variants for their
impact class. Since high impact mutations are generally rare due to their impact on normal gene function, their
enrichment within platform exclusive variant sets is expected. In the same manner, as low impact variants have
no impact on gene function, they are less likely to be identified as platform exclusive within their variant class.
For a small number of genes, a larger number of SNVs was detected using WGS. These genes were mostly
restricted to olfactory receptors on chromosome D1 and genes on the X chromosome that has degraded copies
on the Y. The repetitive nature of olfactory receptors means they are likely to lead to a higher percentage of offtarget reads, especially in pseudo-genes, and decrease mapping quality in legitimate targets. For X chromosome
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WGS biased genes, the increased variant discovery in males is likely a result of some genes residing in the
degenerate X region of the Y chromosome. A collection of ten known X chromosome genes with diverging Y
chromosome copies all showed high levels of sex and platform bias. These genes had more variants in males
since the Y chromosome copies contained a large number of mismatches. Similarly, the divergence of the Y
chromosome could affect the hybridization of Y sequences to X chromosome probes, leading to reduced detection of variants in WES cats. However, the number of variants in females for these genes was largely consistent
across platforms, indicating that discrepancies are most likely due to the presence of the Y chromosome. The
impact from degraded X genes on the Y chromosomes propagated throughout the analysis. WGS exclusive SNVs
were more common in males and the allele count distribution contained a peak at an allele count of four. Even
though male X chromosome carried more variants than female X chromosome across both platforms, the effect
was especially observable in the WGS exclusive dataset and may have otherwise remained hidden without this
comparison. Importantly, while the feline exome set contained probes for DDX3Y, USP9Y, UBE1Y, and KDM5D,
which are all Y chromosome degraded X genes, these genes were not included in the reference genome used
to align reads. Despite this absence of the partial Y assembly, many Y chromosomes degraded X genes do not
have probes designed. Overall, both WGS and WES analysis of cat sex chromosomes will be improved by the
assembly of a domestic cat Y chromosome.
Previously characterized and unknown germline or somatic variants of clinical significance, the former
often not identifiable without the parents, were investigated to confirm if each were identical or unique to genes
associated with each disease or phenotype in prior studies. Known variants were first confirmed to validate the
accuracy of the cat exome design for the following aesthetic traits: Agouti, Brown, Dense, Gloves, Dilution, Extension, Long, Lykoi, and hairless coat types16. In addition, disease variants were found in genes earlier shown to be
candidate alleles in hydrocephalus47, hypertrophic c ardiomyopathy48, and progressive retinal atrophy17. These
results importantly validate our design is capable of detecting variants with prior trait association. Nonetheless,
a primary study objective was to find new potential causal variants in our small mixed disease and trait cohort
of 31 domestic cats. This cohort was searched to find novel candidate variants for three diseases and traits; feline
autosomal dominant polycystic kidney disease (ADPKD), atrichia, hypotricha. ADPKD is a common inherited
autosomal dominant disease affecting about 6% of the world’s cats49 and is characterized by fluid-filled cysts that
form in the bilateral kidneys that often leads to renal failure50. Many of the features of feline ADPKD are similar
to human ADPKD and recent studies demonstrated the utility of the cat m
 odel14,51. The c. 10063C>A mutation
in exon 29 of PKD1 was the only known causative allele for feline ADPKD49, however, for human ADPKD,
variants are found throughout PKD1. A variant in polycystin 2 (PKD2), c.2211delG at position B1:134992553,
causes a p.Lys737Asnfs*2 and was identified in a Siberian cat from Europe, indicating additional alleles may be
segregating for ADPKD in cats.
Domestic cats have various forms of atrichia and hypotricha, which even though each is characterized by
baldness or loss of hair coat, are not considered diseased cats since breeders have selected upon these observed
traits to develop new breeds. Only two breeds are recognized as completely hairless, the Sphynx and Donskoy.
Donskoy cats are a breed of Russian cats in which loss of hair is determined by a semi-dominant a llele52. Peterbald
cats were bred in Russia in 1994 as a product of a Donskoy and an Oriental Shorthair cross, and are often born
with no hair, or lose their hair over time53. Cornish Rex, a hypotrichia breed, that is characterized by a curly coat,
is caused by a homozygous deletion mutation in LPAR654. The Peterbald cat had an LPAR6 4 base pair deletion
that is in juxtaposition to a compound heterozygote for the Cornish rex deletion variant. Both variants result in
premature stop codons a few amino acids downstream of the variant site. Other disease-associated variants were
re-identified, such as cystinuria variants, in which the cat was homozygous and affected. Determination of allele
frequencies through the 99 lives project40 improved the identification of cats that were heterozygous for variants
associated with recessive diseases, such as, p
 orphyria36, Factor XII d
 eficiency55, and copper m
 etabolism38. The
inclusion of 99 Lives WGS data was central to establishing the likelihood of variants being causal for diseases
and further cross-species explorations of variant frequencies promises to better define variants of uncertain
significance56.
Clinical use of sequence variant information in companion animals is in the very early stages, which hampers the ability of veterinarians to rapidly diagnose some diseases without standard or unclear phenotypic
determinants. In the future, it could be used to adapt treatments to the specific animal and disease type57. Many
diagnosed rare diseases have a poor prognosis, with some less than 90 days; thus, cost-effective sequencing
approaches may help discover alternate and more effective treatments. The Undiagnosed Diseases Program of
the National Institutes of Health routinely uses WES for this purpose of finding treatments where none exist,
suggesting veterinary medicine could benefit in the same m
 anner58. We confirm here, as other studies have
shown, that WES is cost-effective, data process-efficient (by requiring less computing time), and easier to use
than WGS for inferring a variant’s biological r elevance59. As in the dog, a first step is offered toward the use of
feline WES for robust disease variant detection, including the validation of previously identified causal alleles
and the discovery of novel candidate variants that we suggest are of interest for further experimental s crutiny60.
We have developed domestic cat-specific WES, and importantly, based on our findings, validated its use for the
evaluation of potential disease variants for the future practice of feline genomic medicine.

Methods

Exome design. The annotated exons from the Felis_catus_9.0 reference genome assembly were used as the
basis to design the exome capture probes, incorporating the NCBI RefSeq release 92 annotation, containing
19,590 refGene names. The coding sequences (CDS) for the primary chromosomes were extracted and consolidated into a non-overlapping set of features, and repetitive probes were removed totaling 35,724,716 bases
divided over 201,683 regions. Of those bases, only 395,115 bp are not covered directly or indirectly. GO funcScientific Reports |
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tions for removed genes were olfactory genes or unidentifiable. Since Y chromosome genes are not represented
in the Felis_catus_9.0 reference, a set of coding sequence features from the Felis catus Y chromosome genomic
sequence (NCBI accession KP081775) was used61. The cat exome panel was designed by Roche Sequencing
Solutions (Madison, USA)62. A capture probe dataset was constructed for the full cat genome by tiling variablelength probes, ranging from 50 to100 bases in length, at a five-base step across all sequences. Each capture probe
was evaluated for repetitiveness by constructing a 15-mer histogram from the full genome sequence and then
calculating the average 15-mer count across each probe, a sliding window size of 15 bases across the length
of each probe. Any probe with an average 15-mer count greater than 100 was considered to be repetitive and
excluded from further characterization. Non-repetitive probes were then scored for uniqueness by aligning each
capture probe to the full cat genome using SSAHA v 363. A close match to the genome was defined as a match
length of 30 bases, allowing up to five insertions/deletions/substitutions. Capture probes were selected for each
coding sequence feature by scoring one to four probes in a 20-base window, based on repetitiveness, uniqueness,
melting temperature, and sequence composition, and then choosing the best capture probe in that window. The
start of the 20 base windows was then moved 40 bases downstream and the process repeated. Selected probes
were allowed to start up to 30 bases before the 5′ start of each feature and overhang the 3′ end by 30 bp. A maximum of five close matches in the genome was allowed when selecting the capture probes.

Samples and DNA isolation. Cat DNA samples for WES were donated by owners and archived in accordance with the University of Missouri Institutional Animal Care and Use Committee protocol study protocols
9056, 9178, and 9642. DNA was isolated from 41 whole blood or tissue cat samples using standard organic
methods64 and verified for quantity and quality by DNA fluorescence assay (Qubit, Thermo Fisher) and ethidium bromide staining after 0.7% agarose gel electrophoresis. Ten cats with existing whole genome sequence
(WGS) data were initially tested, followed by 31 novel cats.
Sequencing. All WGS cat data used in this study was obtained from Beuckley et al.32 Genomic DNA (250 ng)

was fragmented on the Covaris LE220 instrument targeting 250 bp inserts. Automated dual indexed libraries were constructed with the KAPA HTP library prep kit (Roche) on the NGS platform (Perkin Elmer). The
libraries were PCR-amplified with KAPA HiFi for 8 cycles. The final libraries were purified with a 1.0 × AMPureXP bead cleanup and quantitated on the Caliper GX instrument (Perkin Elmer) and were pooled pre-capture
generating a total 5 µg library pool. Each library pool was hybridized with a custom NimbleGen probe set
(Roche), targeting 35.7 Mb. The libraries were hybridized for 16–18 h at 65 °C followed by washing to remove
non-specific hybridized library fragments. Enriched library fragments were eluted following isolation with
streptavidin-coated magnetic beads and amplified with KAPA HiFi Polymerase prior to sequencing. PCR cycle
optimization was performed to prevent over-amplification of the libraries. The concentration of each captured
library pool was determined via qPCR utilizing the KAPA library Quantification Kit (Roche) to produce appropriate cluster counts prior to sequencing. The Illumina NovaSeq6000 instrument was used to generate pairedend 2 × 150 bp length sequences to yield an average of 14 Gb of data per 35.7 Mb target exome, producing
~ 80 × exome sequencing depth of coverage. Exome sequencing data are available at the Sequence Read Archive
under accession number PRJNA627536.

Variant discovery. The following tools/packages were applied to WGS and WES samples in accordance with
variant processing as previously described32 71: BWA-MEM version 0.7.1765, Picard tools version 2.1.1 (http://
broadinstitute.github.io/picard/), Samtools version 1.966, and Genome Analysis toolkit version 3.867–69. Code
used for the variant calling workflow can be found at https://github.com/mu-feline-genome/batch_GATK_workf
low. For WES processing, GATK tools were restricted to exons annotated in Ensembl release 99 with an additional 100 bp of flanking sequence70. Following processing, samples were genotyped in three separate cohorts.
The first cohort consisted of all 41 WES samples. The second and third cohorts were ten matched WES and WGS
samples. Variants in all three cohorts were tagged using the same variant filtering criteria. For SNVs, the filtering
criteria were QD < 2.0, FS > 60.0, SOR > 3.0, ReadPosRankSum < − 8.0, MQ < 40.0, and MQRankSum < − 12.5.
For indels, the filtering criteria were QD < 2.0, FS > 200.0, SOR > 10.0, and ReadPosRankSum < − 20.0. Although
five Y chromosome genes were included in the exome probe set, these genes had not been added to the aligning
reference. For WGS/WES comparison, matched WES/WGS samples were annotated using variant effect predictor release 97(VEP)71. Variants from both cohorts were independently tagged as to whether they were biallelic,
SNVs, or passed filtering criteria. Before analysis, variants flanking the exome primary target regions + /− 2 bp
were removed (Supplementary Data S1). Variant processing and comparisons were performed in the R statistical
environment using the vcfR package version 1.8.072. Common variants between both platforms were determined
as those at the same position with the same reference and alternate alleles. Exclusive variants were determined as
those where the position and/or the alleles were specific to a particular platform.
Disease and trait variant detection. Variants for all 41 cats were evaluated using VarSeq software (GoldenHelix, Inc.). SNVs were annotated as having high, moderate, or low impacts on gene function. High impact
variations were those that were a protein-truncating variant caused by stop gain or loss and splice-site acceptor or donor mutations73. Moderate impacts include missense mutations or in-frame insertions, and lastly, low
impact variants are characterized by synonymous base changes, splice region variants, or intron variants. Known
variants for diseases and traits were evaluated in each cat.
Polycystic kidney disease. A pointed cat of the Siberian breed (a.k.a. Neva Masquerade, a pointed Siberian) was diagnosed with polycystic kidney disease based on signs of renal disease (polydipsia, polyuria) and
Scientific Reports |
Vol:.(1234567890)

(2021) 11:7159 |

https://doi.org/10.1038/s41598-021-86200-7

10

www.nature.com/scientificreports/
ultrasonography (Table 1, cat 37). DNA was submitted using buccal swabs and a whole blood sample to two different commercial testing laboratories in which both confirmed the absence of the currently known autosomal
dominant polycystic kidney disease in polycystin-1 (PKD1)49,74. The dam and a sibling were also reported as
having PKD by ultrasonography but were not available for genetic analyses.

Cystinuria. A 3-month-old European shorthair kitten from the isle of Korfu, Greece, was presented to the

AniCura Small Animal Hospital, Bielefeld, FRG, for heavy straining during urination, and the owner reported
the kitten would fall over from time to time (Table 1, cat 17). The kitten had been pretreated with two injections
of cephalexine and dexamethasone for suspected cystitis, however, difficulty in urination worsened. Upon hospital admission, the kitten was in good general condition. Abdominal palpation revealed an enlarged urinary
bladder. Abdominal X-ray showed over 30 radiolucent urinary stones up to a diameter of half of the width of the
last rib. Urinary bladder stones and some urethral stones were removed via cystolithotomy and retrograde flushing of the urethra. Urinary stones were submitted for infraspectroscopic stone analysis. Stone analysis revealed
pure cystine stones and a diagnosis of cystinuria was made. Urinary stones reoccurred at 6 months of age, but
the kitten was otherwise healthy.

Informed consent. Cat DNA samples for WES were donated by owners. The study protocol was approved
by the University of Missouri Institutional Animal Care and Use Committee protocol study protocols 9056, 9178,
and 9642. All experiments were performed in accordance with relevant guidelines and regulations. Informed
consent was also obtained from owners for involvement for animals in our study.

Data availability

The code for probe design is not available. Roche Sequencing solutions has HyperExplore panels available with
the KAPA Target Enrichment platform for probe design.
Received: 25 September 2020; Accepted: 17 February 2021
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